Ken Fisher's VRDN Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 1.77 M shares of Viridian Therapeutics, Inc. (VRDN) worth $34.59 M, representing 0.01% of the portfolio. First purchased in 2024-Q1, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in VRDN, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 691,267 shares. Largest reduction occurred in Q2 2025, reducing 27,065 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Viridian Therapeutics (VRDN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Viridian Therapeutics (VRDN) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -11,989 | Reduce 0.67% | 1.77 M | $19.56 |
| Q4 2025 | +579,058 | Add 48.21% | 1.78 M | $31.12 |
| Q3 2025 | +691,267 | Add 135.55% | 1.2 M | $21.58 |
| Q2 2025 | -27,065 | Reduce 5.04% | 509,959 | $13.98 |
| Q1 2025 | +18,997 | Add 3.67% | 537,024 | $13.48 |
| Q4 2024 | +23,103 | Add 4.67% | 518,027 | $19.17 |
| Q3 2024 | +99,427 | Add 25.14% | 494,924 | $22.75 |
| Q2 2024 | +6,410 | Add 1.65% | 395,497 | $13.01 |
| Q1 2024 | +389,087 | New Buy | 389,087 | $17.51 |
Ken Fisher's Viridian Therapeutics Investment FAQs
Ken Fisher first purchased Viridian Therapeutics, Inc. (VRDN) in Q1 2024, acquiring 389,087 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Viridian Therapeutics, Inc. (VRDN) for 9 quarters since Q1 2024.
Ken Fisher's largest addition to Viridian Therapeutics, Inc. (VRDN) was in Q3 2025, adding 1,201,226 shares worth $25.92 M.
According to the latest 13F filing for Q1 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 1,768,295 shares of Viridian Therapeutics, Inc. (VRDN), valued at approximately $34.59 M.
As of the Q1 2026 filing, Viridian Therapeutics, Inc. (VRDN) represents approximately 0.01% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Viridian Therapeutics, Inc. (VRDN) was 1,780,284 shares, as reported at the end of Q4 2025.